Research on Earnings Quality of Company H Based on Entropy-Weighted TOPSIS and Grey Relational Analysis

在医药行业竞争白热化且政策频繁变动的当下，H公司作为行业内的关键企业，其盈利质量备受各方关注。本研究综合运用理论与数据相结合的方法，从盈利性、持续稳定性、现金保障性、成长性四个维度选取11个指标，同时借助熵权TOPSIS法和灰色关联分析法，对H公司的盈利质量展开深入且系统的剖析。研究发现，公司在销售现金获取和盈利结构稳定性上有优势，但面临盈利增长不稳定、资金周转压力大以及行业竞争中盈利质量存在差距等问题。基于这些问题，本文提出了强化成本管控、优化盈利结构、调整信用政策和提升研发创新能力等建议，为H公司及医药行业其他企业提升盈利质量提供参考。In the current era, when the competition in the pharmaceutical industry is intense and policies are frequently changing, as a key enterprise in the industry, the profitability quality of Company H has drawn wide attention from all parties. This study comprehensively applies the method of combining theory and data and selects 11 indicators from four dimensions of profitability, sustainable stability, cash guarantee, and growth. Meanwhile, by means of the Entropy-Weighted TOPSIS method and the Grey Relational Analysis method, it conducts an in-depth and systematic analysis of the profitability quality of Company H. The study finds that the company has advantages in obtaining cash from sales and the stability of the profit structure, but it faces problems such as unstable profit growth, high pressure on capital turnover, and gaps in profitability quality in industry competition. Based on these problems, this paper puts forward suggestions such as strengthening cost control, optimizing the profit structure, adjusting the credit policy, and enhancing the R&D and innovation capabilities, providing a reference for Company H and other enterprises in the pharmaceutical industry to improve their profitability quality.